The Journal of Drugs in Dermatology is pleased to publish findings on a new injectable drug currently under development by Kythera Biopharmaceuticals, Inc. (Westlake Village, CA) that may provide a non-surgical alternative for people with double chins.
from The Medical News http://ift.tt/1F5ilSQ
from The Medical News http://ift.tt/1F5ilSQ
No comments:
Post a Comment